STAT Plus: How can cancer drug prices better match their benefits? Germany offers a cost-saving model
GERRY BROOME/AP
A study finds that after Germany revamped its approach to drug pricing, cancer drug prices negotiated by the government were better aligned with benefits.
No hay comentarios:
Publicar un comentario